ArticleBMC infectious diseases2026
Elevated procalcitonin levels in febrile children with exanthema subitum undergoing clinically indicated PCT testing: a retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman herpesvirus 6 (HHV-6), the causative agent of exanthema subitum (ES), is a major viral cause of acute encephalopathy in Japan. Serum procalcitonin (PCT) is widely used as a biomarker of severe bacterial infections and has also been proposed as an early predictor of encephalopathy. However, elevated PCT levels are occasionally observed in ES without bacterial co-infection or encephalopathy, potentially complicating interpretation of PCT levels in febrile children. The association between primary HHV-6 infection and PCT elevation remains unclear. We therefore investigated clinical and laboratory factors associated with serum PCT levels in young children with primary HHV-6 infection.
methodsWe conducted a retrospective cohort study of 188 febrile children aged < 60 months who underwent serum PCT measurement between April 2021 and May 2024. Thirty children with clinically diagnosed ES and laboratory-confirmed primary HHV-6 infection were compared with 53 children with other virologically confirmed febrile illnesses. In exploratory analyses, multivariable logistic regression identified factors associated with ES, and multivariable linear regression explored factors associated with serum PCT levels in the ES group.
resultsMedian serum PCT levels were significantly higher in the ES group than in controls (0.28 [interquartile range (IQR) 0.10-0.61] vs. 0.10 [IQR 0.10-0.31] ng/mL; P = 0.018). The PCT/C-reactive protein ratio was also higher in ES (P = 0.018). ES patients had lower white blood cell, neutrophil, and platelet counts, and higher aspartate aminotransferase and lactate dehydrogenase levels. In exploratory multivariable analysis, younger age (odds ratio [OR] 0.92; 95% confidence interval [CI] 0.87-0.98; P = 0.006), lower platelet count (OR 0.88; 95% CI 0.82-0.94; P < 0.001), and higher PCT level (OR 1.74; 95% CI 1.02-2.95; P = 0.042) were associated with ES. Among patients with ES, lower lymphocyte count and absence of febrile seizures were associated with higher PCT levels. All ES patients had a self-limited clinical course without encephalopathy.
conclusionsAmong febrile children undergoing clinically indicated PCT testing, primary HHV-6 infection was associated with modest PCT elevation. These elevations may reflect HHV-6-associated hematologic alterations rather than bacterial co-infection or disease severity, highlighting the need for cautious interpretation of PCT in ES.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.